$QBTS
D-Wave Quantum Inc Stock $qbts

$qbts Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000190798223000016 Filed on May 19, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$1.707M	$1.583M	$0.00
YoY Change	24.51%
Cost Of Revenue	$1.002M	$1.162M	$584.0K
YoY Change	70.99%	98.97%	95.97%
Gross Profit	$705.0K	$421.0K	$1.129M
YoY Change	-10.19%	-62.71%	1.53%
Gross Profit Margin	41.3%	26.6%
Selling, General & Admin	$12.06M	$14.20M	$5.246M
YoY Change	111.72%	170.61%	46.05%
% of Gross Profit	1711.21%	3371.97%	464.66%
Research & Development	$9.548M	$10.92M	$6.525M
YoY Change	35.01%	67.28%	0.63%
% of Gross Profit	1354.33%	2592.64%	577.95%
Depreciation & Amortization	$200.0K	$339.0K	$412.0K
YoY Change	-35.28%	-17.72%	7.29%
% of Gross Profit	28.37%	80.52%	36.49%
Operating Expenses	$21.61M	$25.11M	$2.187M
YoY Change	69.24%	1048.04%	179.75%
Operating Profit	-$20.91M	-$24.69M	-$1.058M
YoY Change	74.44%	2233.01%	-420.57%
Interest Expense	-$1.130M	$454.0K	$46.38K
YoY Change	-164.72%	878.87%	-22.56%
% of Operating Profit
Other Income/Expense, Net	-$4.991M	$82.00K	-$1.282M
YoY Change	311.46%	-106.4%	-107.95%
Pretax Income	-$25.90M	-$24.61M	-$3.423M
YoY Change	96.24%	619.01%	-122.23%
Income Tax
% Of Pretax Income
Net Earnings	-$25.90M	-$24.60M	-$3.423M
YoY Change	96.24%	618.77%	-122.23%
Net Earnings / Revenue	-1517.28%	-1554.01%
Basic Earnings Per Share	-$0.20	-$0.20	-$0.09
Diluted Earnings Per Share	-$0.20	-$0.20	-$91.27K
COMMON SHARES
Basic Shares Outstanding	80.60M shares	80.39M shares	125.4M shares
Diluted Shares Outstanding	127.3M shares	123.1M shares	125.4M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.510M	$8.988M	$30.75K
YoY Change	-28.24%	29129.27%	-96.67%
Cash & Equivalents	$7.514M	$8.988M	$17.66M
Short-Term Investments
Other Short-Term Assets	$2.200M	$2.814M	$123.4K
YoY Change	-69.44%	2181.13%	-68.92%
Inventory	$2.325M	$2.240M	$2.052M
Prepaid Expenses
Receivables	$803.0K	$542.0K	$2.820M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.84M	$14.91M	$154.1K
YoY Change	-44.61%	9576.21%	-88.34%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.792M	$2.041M	$11.34M
YoY Change	-35.35%	-82.0%
Goodwill
YoY Change
Intangibles	$205.0K	$228.0K
YoY Change	-21.76%
Long-Term Investments			$300.2M
YoY Change			0.04%
Other Assets	$1.354M	$1.351M	$1.354M
YoY Change	0.3%	-0.22%
Total Long-Term Assets	$12.07M	$12.55M	$300.2M
YoY Change	-3.48%	-95.82%	0.04%
TOTAL ASSETS
Total Short-Term Assets	$12.84M	$14.91M	$154.1K
Total Long-Term Assets	$12.07M	$12.55M	$300.2M
Total Assets	$24.91M	$27.46M	$300.4M
YoY Change	-30.2%	-90.86%	-0.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.110M	$8.067M	$3.052M
YoY Change	65.53%	164.32%
Accrued Expenses	$10.80M	$9.859M	$7.813M
YoY Change	30.2%	26.19%	768.68%
Deferred Revenue	$2.827M	$1.827M
YoY Change	8.94%
Short-Term Debt	$210.0K	$420.0K	$200.0K
YoY Change		110.0%
Long-Term Debt Due	$15.91M	$790.0K	$15.28M
YoY Change	-25.49%	-94.83%
Total Short-Term Liabilities	$33.64M	$18.08M	$4.930M
YoY Change	-7.32%	266.85%	448.09%
LONG-TERM LIABILITIES
Long-Term Debt	$8.473M	$8.260M	$0.00
YoY Change	-34.33%
Other Long-Term Liabilities	$10.69M	$8.428M	$22.57M
YoY Change		-62.66%	-31.77%
Total Long-Term Liabilities	$8.473M	$8.260M	$22.57M
YoY Change	-34.33%	-63.4%	-31.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.64M	$18.08M	$4.930M
Total Long-Term Liabilities	$8.473M	$8.260M	$22.57M
Total Liabilities	$52.80M	$34.77M	$27.50M
YoY Change	-5.34%	26.45%	-19.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$427.3M	-$401.4M
YoY Change	22.05%
Common Stock	$12.00K	$12.00K
YoY Change	-99.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$27.89M	-$7.313M	$272.9M
YoY Change
Total Liabilities & Shareholders Equity	$24.91M	$27.46M	$300.4M
YoY Change	-30.2%	-90.86%	-0.35%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$25.90M	-$24.60M	-$3.423M
YoY Change	96.24%	618.77%	-122.23%
Depreciation, Depletion And Amortization	$200.0K	$339.0K	$412.0K
YoY Change	-35.28%	-17.72%	7.29%
Cash From Operating Activities	-$15.47M	-$13.60M	-$294.0K
YoY Change	29.02%	4526.32%	83.77%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$64.00K	-$144.0K
YoY Change	-100.0%	-144.44%	-80.51%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	-$76.00K	-$144.0K
YoY Change	-100.0%	-47.22%	-80.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$881.0K	$13.00K
YoY Change		6676.92%
Cash From Financing Activities	14.07M	$15.59M	200.0K
YoY Change	187.55%	7696.0%	-98.32%
NET CHANGE
Cash From Operating Activities	-15.47M	-$13.60M	-294.0K
Cash From Investing Activities	0.000	-$76.00K	-144.0K
Cash From Financing Activities	14.07M	$15.59M	200.0K
Net Change In Cash	-1.400M	$1.923M	-93.97K
YoY Change	-80.48%	-2146.4%	-41.26%
FREE CASH FLOW
Cash From Operating Activities	-$15.47M	-$13.60M	-$294.0K
Capital Expenditures	$0.00	$64.00K	-$144.0K
Free Cash Flow	-$15.47M	-$13.66M	-$150.0K
YoY Change	29.83%	9011.16%	-125.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	qbts	Equity Line Of Credit Ownership Restriction Percentage EquityLineOfCreditOwnershipRestrictionPercentage	0.099
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001907982
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-41468
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	D-WAVE QUANTUM INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-1068854
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3033 Beta Avenue
CY2023Q1	qbts	Working Capital Deficit WorkingCapitalDeficit	-3200000	usd
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Burnaby
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	BC
CY2023Q1	dei	Entity Address Country EntityAddressCountry	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	V5G 4M9
CY2023Q1	dei	City Area Code CityAreaCode	604
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	630-1428
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q1	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	80600419	shares
CY2023Q1	us-gaap	Cash Cash	8988000	usd
CY2022Q4	us-gaap	Cash Cash	7065000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	542000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	757000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	2240000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	2196000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3142000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3907000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	14912000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	13925000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2041000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2294000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8927000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9133000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	228000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	244000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1351000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1351000	usd
CY2023Q1	us-gaap	Assets Assets	27459000	usd
CY2022Q4	us-gaap	Assets Assets	26947000	usd
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	5608000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	3756000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9859000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8640000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	790000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1671000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1827000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18084000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	15848000	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1254000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1892000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7165000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7301000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8260000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7811000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	34772000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	32861000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	675000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127173552	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127173552	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	113335530	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	113335530	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	12000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	404501000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	381274000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-401405000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-376797000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10421000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10402000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7313000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5914000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27459000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	26947000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1583000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1713000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	1162000	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	616000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	421000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1097000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10915000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6802000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11296000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3646000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2900000	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1600000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	25111000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	12048000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-24690000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-10951000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	454000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	525000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-638000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-102000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-181000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	82000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-706000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24608000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11657000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123144097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	123144097	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125385841	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125385841	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24608000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11657000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-19000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-70000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-24627000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11727000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3020000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	783000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-70000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11657000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-7917000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5914000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	546000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	15683000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6755000	usd
CY2023Q1	qbts	Adjustments To Additional Paid In Capital Short Swing Profit Settlement AdjustmentsToAdditionalPaidInCapitalShortSwingProfitSettlement	244000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-19000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24608000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-7313000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24608000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11657000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	339000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	412000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6755000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	783000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	206000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	227000	usd
CY2023Q1	qbts	Noncash Interest Expense NoncashInterestExpense	437000	usd
CY2022Q1	qbts	Noncash Interest Expense NoncashInterestExpense	525000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-638000	usd
CY2022Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-44000	usd
CY2022Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-527000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-215000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	321000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	59000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	205000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-767000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1952000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	1858000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-395000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1214000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2936000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	46000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-163000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-150000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-226000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13574000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9509000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64000	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	123000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	12000	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	21000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-76000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-144000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	15683000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	0	usd
CY2022Q1	qbts	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	3178000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	546000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	14700000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	881000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13000	usd
CY2023Q1	qbts	Proceeds From Short Swing Profit Settlement ProceedsFromShortSwingProfitSettlement	244000	usd
CY2022Q1	qbts	Proceeds From Short Swing Profit Settlement ProceedsFromShortSwingProfitSettlement	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15592000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17872000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-19000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-41000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1923000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8178000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7065000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9483000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8988000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17661000	usd
CY2023Q1	qbts	Deferred Costs Incurred But Not Yet Paid DeferredCostsIncurredButNotYetPaid	0	usd
CY2022Q1	qbts	Deferred Costs Incurred But Not Yet Paid DeferredCostsIncurredButNotYetPaid	3734000	usd
CY2022Q2	qbts	Equity Line Of Credit Right To Sell Common Stock EquityLineOfCreditRightToSellCommonStock	150000000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Nature Of Operations NatureOfOperations	Description of business<div style="margin-bottom:0.11pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave Quantum Inc. ("D-Wave" or the “Company”) was incorporated under the General Corporation Law of the State of the Delaware on January 24, 2022. The Company was formed for the purpose of effecting a merger between DPCM Capital, Inc. (“DPCM”), D-Wave Systems Inc. (“D-Wave Systems”), and certain other affiliated entities through a series of transactions (the “Merger”) pursuant to the definitive agreement entered into on February 7, 2022 (the “Transaction Agreement”). On August 5, 2022, in conjunction with the Merger, DPCM and D-Wave Systems became wholly-owned subsidiaries of, and are operated by, the Company. Upon the completion of the Merger, the Company succeeded to all of the operations of its predecessor, D-Wave Systems. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave is a commercial quantum computing company that provides customers with a full suite of professional services and web-based access to its superconducting quantum computer systems and integrated software environment through its cloud service, Leap</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Historically, the Company has developed its own annealing superconducting quantum computer and associated software, and its current generation quantum system is the Advantage</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> system.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D-Wave has three operating facilities, which it leases, in North America. These facilities are located in Burnaby, British Columbia, Richmond, British Columbia, and Palo Alto, California.</span></div>
CY2023Q1	qbts	Number Of Operating Facilities NumberOfOperatingFacilities	3	facility
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-401400000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-24600000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-11700000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13600000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9500000	usd
CY2023Q1	us-gaap	Cash Cash	9000000.0	usd
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2023Q1	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	15700000	usd
CY2023Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	13239654	shares
CY2023Q1	qbts	Equity Line Of Credit Right To Sell Common Stock EquityLineOfCreditRightToSellCommonStock	35000000	usd
CY2022Q2	qbts	Equity Line Of Credit Floor Stock Price EquityLineOfCreditFloorStockPrice	1.00
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Use of estimates</span></div><div style="margin-bottom:0.11pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company’s condensed consolidated financial statements and accompanying notes as of the date of the condensed consolidated financial statements. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. On an ongoing basis, management evaluates its estimates as there are changes in circumstances, facts, and experience.</span></div>The Company’s accounting estimates and assumptions may change over time in response to risks and uncertainties, including uncertainty in the current economic environment due to inflation, increased interest rates, Ukraine/Russia conflict, and any evolutions thereof. The change could be material in future periods. As of the date of issuance of these condensed consolidated financial statements, the Company is not aware of any specific event or circumstances that would require the Company to update estimates, judgments or revise the carrying value of any assets or liabilities. Actual results may differ from those estimates or assumptions.
CY2023Q1	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1200000	usd
CY2022Q4	us-gaap	Equity Securities Without Readily Determinable Fair Value Amount EquitySecuritiesWithoutReadilyDeterminableFairValueAmount	1200000	usd
CY2023Q1	qbts	Class Of Warrant Or Right Quoted Price ClassOfWarrantOrRightQuotedPrice	0.07
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17916609	shares
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1583000	usd
CY2023Q1	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	0	usd
CY2022Q1	qbts	Scientific Research And Experimental Development Investment Tax Credit ScientificResearchAndExperimentalDevelopmentInvestmentTaxCredit	400000	usd
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	qbts	Reverse Recapitalization Conversion Ratio ReverseRecapitalizationConversionRatio	1
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2022Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	40000000	usd
CY2022Q3	qbts	Commitment Fee Liability CommitmentFeeLiability	2600000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1713000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1583000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1713000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1583000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1713000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	542000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	757000	usd
CY2023Q1	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	59000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	58000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	601000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	815000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1827000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1781000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	9000	usd
CY2023Q1	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	45000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability ContractWithCustomerDepositLiability	45000	usd
CY2023Q1	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	1881000	usd
CY2022Q4	qbts	Contract With Customer Liability And Deposit ContractWithCustomerLiabilityAndDeposit	1835000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1790000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2719000	usd
CY2023Q1	qbts	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	1166000	usd
CY2022	qbts	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	5325000	usd
CY2023Q1	qbts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	1120000	usd
CY2022	qbts	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	6254000	usd
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1836000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1790000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1800000	usd
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.99
CY2023Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1800000	usd
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.99
CY2022Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q4	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	2459000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2243000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1858000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2392000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1641000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	211000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	233000	usd
CY2023Q1	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	605000	usd
CY2022Q4	qbts	Accrued Payroll Expenses Current AccruedPayrollExpensesCurrent	451000	usd
CY2023Q1	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	45000	usd
CY2022Q4	qbts	Contract With Customer Deposit Liability Current ContractWithCustomerDepositLiabilityCurrent	45000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1484000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1533000	usd
CY2023Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	420000	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	420000	usd
CY2023Q1	qbts	Accrued Transaction Costs Current AccruedTransactionCostsCurrent	2459000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9859000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8640000	usd
CY2023Q1	qbts	Prepaid Services Current PrepaidServicesCurrent	348000	usd
CY2022Q4	qbts	Prepaid Services Current PrepaidServicesCurrent	391000	usd
CY2023Q1	qbts	Prepaid Software Current PrepaidSoftwareCurrent	403000	usd
CY2022Q4	qbts	Prepaid Software Current PrepaidSoftwareCurrent	559000	usd
CY2023Q1	us-gaap	Prepaid Rent PrepaidRent	160000	usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	96000	usd
CY2023Q1	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	223000	usd
CY2022Q4	qbts	Prepaid Commissions Current PrepaidCommissionsCurrent	268000	usd
CY2023Q1	us-gaap	Prepaid Insurance PrepaidInsurance	871000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	697000	usd
CY2023Q1	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	128000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	89000	usd
CY2023Q1	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	580000	usd
CY2022Q4	qbts	Directors And Officers Insurance Current DirectorsAndOfficersInsuranceCurrent	1449000	usd
CY2023Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	59000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	58000	usd
CY2023Q1	us-gaap	Deposits Assets Current DepositsAssetsCurrent	42000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	36000	usd
CY2023Q1	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	328000	usd
CY2022Q4	qbts	Receivable Research Incentives Current ReceivableResearchIncentivesCurrent	264000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3142000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3907000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25461000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	25405000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23420000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23111000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2041000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2294000	usd
CY2023Q1	us-gaap	Depreciation Depreciation	300000	usd
CY2022Q1	us-gaap	Depreciation Depreciation	300000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28941000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	29844000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	1808000	usd
CY2023Q1	qbts	Debt Instrument Foreign Exchange Gain Loss DebtInstrumentForeignExchangeGainLoss	-46000	usd
CY2022	qbts	Debt Instrument Foreign Exchange Gain Loss DebtInstrumentForeignExchangeGainLoss	1903000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28106000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	28941000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	19459000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	17391000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	437000	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2483000	usd
CY2023Q1	qbts	Debt Instrument Discount Government Assistance DebtInstrumentDiscountGovernmentAssistance	0	usd
CY2022	qbts	Debt Instrument Discount Government Assistance DebtInstrumentDiscountGovernmentAssistance	5673000	usd
CY2023Q1	qbts	Debt Instrument Discount Foreign Exchange Gain Loss DebtInstrumentDiscountForeignExchangeGainLoss	34000	usd
CY2022	qbts	Debt Instrument Discount Foreign Exchange Gain Loss DebtInstrumentDiscountForeignExchangeGainLoss	-1122000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	19056000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	19459000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	9050000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	9482000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	790000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1671000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	8260000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7811000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	9050000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	9482000	usd
CY2023Q1	qbts	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	17916609	shares
CY2022Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2022Q3	qbts	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Prior To Exchange Ratio ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsPriorToExchangeRatio	11.50
CY2022Q3	qbts	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.4541326
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	7.91
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Price ClassOfWarrantOrRightRedemptionPrice	0.10
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdTradingDays	20	day
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Share Price Threshold Consecutive Trading Days ClassOfWarrantOrRightRedemptionSharePriceThresholdConsecutiveTradingDays	P30D
CY2022Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2022Q3	qbts	Class Of Warrant Or Right Reference Value ClassOfWarrantOrRightReferenceValue	18.00
CY2022Q3	qbts	Class Of Warrant Or Right Redemption Notice Period ClassOfWarrantOrRightRedemptionNoticePeriod	P30D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	15387546	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	8763000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	672583	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.81
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	40000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	45731	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.14
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	26821	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.81
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	14642411	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.72
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y5M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11919869	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.02
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M1D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	3544841	shares
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.84
CY2023Q1	qbts	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P8Y9M
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	6400000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1200000	usd
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	500000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6755000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	783000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	400000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	400000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-24608000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-24608000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11657000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11657000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	123144097	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	123144097	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125385841	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125385841	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41969132	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17292166	shares
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31

Files In Submission

Name	View Source	Status
0001907982-23-000016-index-headers.html	Edgar Link	pending
0001907982-23-000016-index.html	Edgar Link	pending
0001907982-23-000016.txt	Edgar Link	pending
0001907982-23-000016-xbrl.zip	Edgar Link	pending
exhibit311-q12023.htm	Edgar Link	pending
exhibit312-q12023.htm	Edgar Link	pending
exhibit321-q12023.htm	Edgar Link	pending
exhibit322-q12023.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qbts-20230331.htm	Edgar Link	pending
qbts-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qbts-20230331_def.xml	Edgar Link	unprocessable
qbts-20230331_cal.xml	Edgar Link	unprocessable
qbts-20230331_lab.xml	Edgar Link	unprocessable
qbts-20230331_pre.xml	Edgar Link	unprocessable
qbts-20230331_htm.xml	Edgar Link	completed
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QBTS
D-Wave Quantum Inc Stock $qbts

2023 Q2 Form 10-Q Financial Statement

#000190798223000016 Filed on May 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS D-Wave Quantum Inc Stock $qbts

2023 Q2 Form 10-Q Financial Statement

#000190798223000016 Filed on May 19, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QBTS
D-Wave Quantum Inc Stock $qbts